Lynparza (olaparib) is a PARP inhibitor that treats various cancers with BRCA1/2 or ATM gene mutations, including ovarian, breast, pancreatic, and prostate cancers. This oral medication blocks the PARP enzyme cancer cells need for DNA repair, causing cancer cells with existing DNA repair defects to die while sparing normal cells. For patients seeking cheap medication online options, working with healthcare providers ensures proper genetic testing before starting, monthly blood monitoring for the first year, and access to legitimate cancer medications through trusted prescription delivery services.